drugset / Trial / NCT05222204
DDP ip Combined With AG in PDAC With Peritoneal Metastasis
NaSingle-groupOpen-labelTreatment
Summary
intraperitoneal (IP) Cisplatin combined with intravenous gemcitabine + nab-paclitaxel in patients with pancreatic cancer with peritoneal metastasis
Timeline
- Start
- 2022-05-15
- Primary completion
- 2024-07-08
- Completion
- 2024-12-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cisplatin | Other / unclassified | — | Intrathecal |
| Subject | Gemcitabine | Small molecule | — | Intravenous |
| Subject | Nab-paclitaxel | Small molecule | — | Intravenous |